Introduction: Metal-based nanoparticles (MBNPs) have attracted considerable interest as antibacterial materials because they can act on bacterial cells through multiple mechanisms and can be tailored for diverse antimicrobial applications.
Aim: This narrative review examined the antibacterial activity of major MBNP classes, emphasizing their mechanisms of action, activity against bacterial biofilms, potential applications, and current limitations.
Materials and Methods: Relevant literature on silver, gold, copper and copper oxide, zinc oxide, titanium dioxide, and iron-based nanoparticles was reviewed. Particular attention was given to their activity against Gram-positive and Gram-negative bacteria, the mechanisms involved in bacterial damage, and their reported effects on bacterial biofilms.
Results and Conclusion: The reviewed studies demonstrate antibacterial activity across all major MBNP classes, although the nature and extent of the effects differ among nanomaterials. Several mechanisms are involved, including disruption of the bacterial envelope, release of metal ions, generation of reactive oxygen species, interference with proteins and enzymes, DNA damage, and disruption of cellular metabolism. The microbicidal potency of some MBNPs is fortified through functionalized, photocatalytic, or magnetically responsive antimicrobial systems (e.g., iron-based MBNPs). Some types of MBNPs have additionally shown activity against bacterial biofilms. Metal-based nanoparticles provide several routes for antibacterial action and offer possibilities that extend beyond direct bacterial killing. Their future value may lie particularly in antimicrobial coatings, delivery systems, combination approaches, and other applications that leverage both their antibacterial and material-specific properties. Pharmaceutical development of MBNP therapeutic systems should consider antibacterial efficacy along with biological safety and performance under conditions relevant to the intended route of application.
Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221-48. doi: 10.1016/S0140-6736(22)02185-7.
Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55. doi: 10.1016/S0140-6736(21)02724-0.
Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025;25(9):1033-43. doi: 10.1016/S1473-3099(25)00118-5.
Mirghani R, Saba T, Khaliq H, Mitchell J, Do L, Chambi L, et al. Biofilms: formation, drug resistance and alternatives to conventional approaches. AIMS Microbiol. 2022;8(3):239-77. doi: 10.3934/microbiol.2022019.
Grooters KE, Ku JC, Richter DM, Krinock BA, Minor KA, Li P, et al. Strategies for combating antibiotic resistance in bacterial biofilms. Front Cell Infect Microbiol. 2024;14:1352273. doi: 10.3389/fcimb.2024.1352273.
Franco D, Calabrese G, Guglielmino SPP, Conoci S. Metal-based nanoparticles: antibacterial mechanisms and biomedical application. Microorganisms. 2022;10(9):1778. doi: 10.3390/microorganisms10091778.
Wahab S, Salman A, Khan Z, Khan S, Krishnaraj C, Yun SI. Metallic nanoparticles: a promising arsenal against antimicrobial resistance—unraveling mechanisms and enhancing medication efficacy. Int J Mol Sci. 2023;24(19):14897. doi: 10.3390/ijms241914897.
Algadi H, Alhoot MA, Al-Maleki AR, Purwitasari N. Effects of metal and metal oxide nanoparticles against biofilm-forming bacteria: a systematic review. J Microbiol Biotechnol. 2024;34(9):1748-56. doi: 10.4014/jmb.2403.03029.
Menichetti A, Mavridi-Printezi A, Mordini D, Montalti M. Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. J Funct Biomater. 2023;14(5):244. doi: 10.3390/jfb14050244.
Gautam S, Das DK, Kaur J, Kumar A, Ubaidullah M, Hasan M, et al. Transition metal-based nanoparticles as potential antimicrobial agents: recent advancements, mechanistic, challenges, and future prospects. Discov Nano. 2023;18:84. doi: 10.1186/s11671-023-03861-1.
Chernavskii PA, Peskov NV, Mugtasimov AV, Lunin VV. Oxidation of metal nanoparticles: experiment and model. Russ J Phys Chem B. 2007;1(4):394-411. doi: 10.1134/S1990793107040082.
Chaparro D, Goudeli E. Oxidation rate and crystallinity dynamics of silver nanoparticles at high temperatures. J Phys Chem C. 2023;127(27):13389-97. doi: 10.1021/acs.jpcc.3c03163.
Mammari N, Lamouroux E, Boudier A, Duval RE. Current knowledge on the oxidative-stress-mediated antimicrobial properties of metal-based nanoparticles. Microorganisms. 2022;10(2):437. doi: 10.3390/microorganisms10020437.
Ivanova N, Ermenlieva N, Simeonova L, Kolev I, Slavov I, Karashanova D, et al. Chlorhexidine-silver nanoparticle conjugation leading to antimicrobial synergism but enhanced cytotoxicity. Pharmaceutics. 2023;15(9):2298. doi: 10.3390/pharmaceutics15092298.
Ivanova N, Ermenlieva N, Simeonova L, Vilhelmova-Ilieva N, Bratoeva K, Stoyanov G, et al. In situ gelling behavior and biopharmaceutical characterization of nano-silver-loaded poloxamer matrices designed for nasal drug delivery. Gels. 2024;10(6):385. doi: 10.3390/gels10060385.
Liao Y, Wang X, Chen P, Zhong Q, Gong J. Antimicrobial mechanisms of metal-based nanomaterials. Int J Nanomedicine. 2025;20:12879-87. doi: 10.2147/IJN.S557649.
More PR, Pandit S, De Filippis A, Franci G, Mijakovic I, Galdiero M. Silver nanoparticles: bactericidal and mechanistic approach against drug resistant pathogens. Microorganisms. 2023;11(2):369. https://doi.org/10.3390/microorganisms11020369.
Ivanova N, Gugleva V, Dobreva M, Pehlivanov I, Stefanov S, Andonova V. Silver nanoparticles as multi-functional drug delivery systems. In: Farrukh MA, editor. Nanomedicines. London: IntechOpen; 2018. p. 71-91. doi: 10.5772/intechopen.80238.
Rodrigues AS, Batista JGS, Rodrigues MÁV, Thipe VC, Minarini LAR, Lopes PS, et al. Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics. Front Microbiol. 2024;15:1440065. doi: 10.3389/fmicb.2024.1440065.
Liu B, Liu D, Chen T, Wang X, Xiang H, Wang G, et al. iTRAQ-based quantitative proteomic analysis of the antibacterial mechanism of silver nanoparticles against multidrug-resistant Streptococcus suis. Front Microbiol. 2023;14:1293363. doi: 10.3389/fmicb.2023.1293363.
Liu HY, Prentice EL, Webber MA. Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob Resist. 2024;2(1):27. doi: 10.1038/s44259-024-00046-3.
Janzadeh A, Behroozi Z, Saliminia F, Janzadeh N, Arzani H, Tanha K, et al. Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis. Forensic Toxicol. 2022;40(1):49-63. doi: 10.1007/s11419-021-00589-4.
Saed MM, Ayivi RD, Wei J, Obare SO. Gold nanoparticles antibacterial activity: does the surface matter? Colloid Interface Sci Commun. 2024;62:100804. doi: 10.1016/j.colcom.2024.100804.
Gudkov SV, Burmistrov DE, Fomina PA, Validov SZ, Kozlov VA. Antibacterial properties of copper oxide nanoparticles (review). Int J Mol Sci. 2024;25(21):11563. doi: 10.3390/ijms252111563.
Irede EL, Awoyemi RF, Owolabi B, Aworinde OR, Kajola RO, Hazeez A, et al. Cutting-edge developments in zinc oxide nanoparticles: synthesis and applications for enhanced antimicrobial and UV protection in healthcare solutions. RSC Adv. 2024;14(29):20992-21034. doi: 10.1039/D4RA02452D.
Serov DA, Gritsaeva AV, Yanbaev FM, Simakin AV, Gudkov SV. Review of antimicrobial properties of titanium dioxide nanoparticles. Int J Mol Sci. 2024;25(19):10519. doi: 10.3390/ijms251910519.
Zhang TG, Miao CY. Iron oxide nanoparticles as promising antibacterial agents of new generation. Nanomaterials (Basel). 2024;14(15):1311. doi: 10.3390/nano14151311.
Crisan MC, Pandrea SL, Matros L, Mocan T, Mocan L. In vitro antimicrobial activity of silver nanoparticles against selected Gram-negative and Gram-positive pathogens. Med Pharm Rep. 2024;97(3):280-97. doi: 10.15386/mpr-2750.
Aguilar-Garay R, Lara-Ortiz LF, Campos-López M, Gonzalez-Rodriguez DE, Gamboa-Lugo MM, Mendoza-Pérez JA, et al. A comprehensive review of silver and gold nanoparticles as effective antibacterial agents. Pharmaceuticals (Basel). 2024;17(9):1134. doi: 10.3390/ph17091134.
Vanlalveni C, Ralte V, Zohmingliana H, Das S, Anal JMH, Lallianrawna S, et al. A review of microbes mediated biosynthesis of silver nanoparticles and their enhanced antimicrobial activities. Heliyon. 2024;10(11):e32333. doi: 10.1016/j.heliyon.2024.e32333.
Krychowiak-Maśnicka M, Wojciechowska WP, Bogaj K, Bielicka-Giełdoń A, Czechowska E, Ziąbka M, et al. The substantial role of cell and nanoparticle surface properties in the antibacterial potential of spherical silver nanoparticles. Nanotechnol Sci Appl. 2024;17:227-46. doi: 10.2147/NSA.S489407.
Chegini Z, Shariati A, Alikhani MY, Safaiee M, Rajaeih S, Arabestani M, et al. Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus. Front Bioeng Biotechnol. 2024;12:1455385. doi: 10.3389/fbioe.2024.1455385.
Khalifa HO, Oreiby A, Mohammed T, Abdelhamid MAA, Sholkamy EN, Hashem H, et al. Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria. Front Cell Infect Microbiol. 2025;15:1599113. doi: 10.3389/fcimb.2025.1599113.
Timoszyk A, Grochowalska R. Mechanism and antibacterial activity of gold nanoparticles (AuNPs) functionalized with natural compounds from plants. Pharmaceutics. 2022;14(12):2599. doi: 10.3390/pharmaceutics14122599.
Sun Y, Xu W, Jiang C, Zhou T, Wang Q, Lan A. Gold nanoparticle decoration potentiate the antibacterial enhancement of TiO₂ nanotubes via sonodynamic therapy against peri-implant infections. Front Bioeng Biotechnol. 2022;10:1074083. doi: 10.3389/fbioe.2022.1074083.
Ge P, Zhang J, Ding T, Xianyu Y. Surface chemistry of gold nanoparticles for bacterial detection and antimicrobial applications. ACS Mater Lett. 2023;5(3):638-55. doi: 10.1021/acsmaterialslett.2c00923.
Ma X, Zhou S, Xu X, Du Q. Copper-containing nanoparticles: mechanism of antimicrobial effect and application in dentistry—a narrative review. Front Surg. 2022;9:905892. doi: 10.3389/fsurg.2022.905892.
Woźniak-Budych MJ, Staszak K, Staszak M. Copper and copper-based nanoparticles in medicine—perspectives and challenges. Molecules. 2023;28(18):6687. doi: 10.3390/molecules28186687.
Pellosi DS, Paiva GSM, Vital VG, Mendes AL, Santos NG, Kuriki FK, et al. Harnessing copper nanoparticles for antimicrobial applications: advances and challenges. Antibiotics (Basel). 2025;14(11):1170. doi: 10.3390/antibiotics14111170.
El-Saadony MT, Fang G, Yan S, Alkafaas SS, El Nasharty MA, Khedr SA, et al. Green synthesis of zinc oxide nanoparticles: preparation, characterization, and biomedical applications—a review. Int J Nanomedicine. 2024;19:12889-937. doi: 10.2147/IJN.S487188.
Ahmad I, Alshahrani MY, Wahab S, Al-Harbi AI, Nisar N, Alraey Y, et al. Zinc oxide nanoparticle: an effective antibacterial agent against pathogenic bacterial isolates. J King Saud Univ Sci. 2022;34(5):102110. doi: 10.1016/j.jksus.2022.102110.
Caron AJ, Ali IJ, Delgado MJ, Johnson D, Reeks JM, Strzhemechny YM, et al. Zinc oxide nanoparticles mediate bacterial toxicity in Mueller-Hinton Broth via Zn²⁺. Front Microbiol. 2024;15:1394078. doi: 10.3389/fmicb.2024.1394078.
El-Habib I, Maatouk H, Lemarchand A, Dine S, Roynette A, Mielcarek C, et al. Antibacterial size effect of ZnO nanoparticles and their role as additives in emulsion waterborne paint. J Funct Biomater. 2024;15(7):195. doi: 10.3390/jfb15070195.
Lazić V, Nikšić V, Nedeljković JM. Application of TiO₂ in photocatalytic bacterial inactivation: review. Int J Mol Sci. 2025;26(21):10593. doi: 10.3390/ijms262110593.
Schutte-Smith M, Erasmus E, Mogale R, Marogoa N, Jayiya A, Visser HG. Using visible light to activate antiviral and antimicrobial properties of TiO₂ nanoparticles in paints and coatings: focus on new developments for frequent-touch surfaces in hospitals. J Coat Technol Res. 2023;20(3):789-817. doi: 10.1007/s11998-022-00733-8.
Tzevelekidis P, Theodosiou M, Papadopoulou A, Sakellis E, Boukos N, Bikogiannakis AK, et al. Visible-light-activated antibacterial and antipollutant properties of biocompatible Cu-doped and Ag-decorated TiO₂ nanoparticles. Heliyon. 2024;10(17):e35634. doi: 10.1016/j.heliyon.2024.e35634.
Vasić K, Knez Ž, Leitgeb M. Multifunctional iron oxide nanoparticles as promising magnetic biomaterials in drug delivery: a review. J Funct Biomater. 2024;15(8):227. doi: 10.3390/jfb15080227.
Lu Z, Yu D, Nie F, Wang Y, Chong Y. Iron nanoparticles open up new directions for promoting healing in chronic wounds in the context of bacterial infection. Pharmaceutics. 2023;15(9):2327. doi: 10.3390/pharmaceutics15092327.
Gudkov SV, Burmistrov DE, Serov DA, Rebezov MB, Semenova AA, Lisitsyn AB. Do iron oxide nanoparticles have significant antibacterial properties? Antibiotics (Basel). 2021;10(7):884. doi: 10.3390/antibiotics10070884.